JPMorgan Chase & Co. reissued their underweight rating on shares of Diploma (LON:DPLM – Get Rating) in a research report sent to investors on Monday, LSE.Co.UK reports. They currently have a GBX 2,150 ($26.20) price objective on the stock.
Other research analysts also recently issued reports about the company. Berenberg Bank reiterated a buy rating and issued a GBX 3,360 ($40.95) price target on shares of Diploma in a report on Tuesday, February 21st. Barclays reiterated an overweight rating and issued a GBX 3,290 ($40.10) price target on shares of Diploma in a report on Tuesday, November 22nd. Deutsche Bank Aktiengesellschaft reiterated a hold rating and issued a GBX 2,450 ($29.86) price target on shares of Diploma in a report on Tuesday, November 22nd. Finally, Royal Bank of Canada lifted their price target on Diploma from GBX 2,450 ($29.86) to GBX 2,700 ($32.91) and gave the company a sector perform rating in a report on Tuesday, November 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Diploma currently has a consensus rating of Hold and an average target price of GBX 2,790 ($34.00).
Diploma Trading Down 0.5 %
Shares of LON DPLM opened at GBX 2,644 ($32.22) on Monday. Diploma has a twelve month low of GBX 2,090 ($25.47) and a twelve month high of GBX 3,022 ($36.83). The business has a fifty day simple moving average of GBX 2,818.84 and a two-hundred day simple moving average of GBX 2,679.28. The firm has a market cap of £3.30 billion, a PE ratio of 3,591.89, a price-to-earnings-growth ratio of 2.82 and a beta of 0.70. The company has a quick ratio of 0.80, a current ratio of 1.63 and a debt-to-equity ratio of 65.80.
Diploma Increases Dividend
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- First Republic: First Rate Risk or Time To Buy?
- These Hedge Funds Are Getting Crushed By SVB
- Buy The Dip In The Charles Schwab Corporation
- ZIM Integrated Shipping Services: Up 15% But Don’t Chase It
- FedEx Is A Buy Going Into Earnings
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.